PD-1 阻塞剂
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
尼沃卢马布和潘布罗利祖马布是单克隆抗体,可以阻断编程死亡-1 (PD-1) 受体. 这种免疫治疗方法抑制了抗瘤免疫反应,导致最近获得了黑色素瘤和非小细胞肺癌的批准.
科学领域:
- 免疫学
- 癌症学
- 药理学
背景情况:
- 单克隆抗体nivolumab和pembrolizumab的目标是编程死亡-1 (PD-1) 受体.
- 阻断PD-1受体增强了瘤特异性的免疫反应.
研究的目的:
- 概述PD-1抑制剂的机制和最近的治疗批准.
- 突出PD-1阻断在癌症治疗中的作用.
主要方法:
- 对PD-1抑制剂的科学文献的审查.
- 对nivolumab和pembrolizumab的临床试验数据的分析.
主要成果:
- 尼沃卢马布和潘布罗利祖马布有效地阻断PD-1受体.
- 这些药物可以抑制抗瘤免疫反应.
结论:
- 尼沃卢马布和潘布罗利祖马布在癌症免疫治疗方面取得了重大进展.
- 最近对转移性黑色素瘤和非小细胞肺癌的批准强调了它们的临床实用性.
更多相关视频
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Drugs Acting on Autonomic Ganglia: Blockers
